Neonatal blue-light phototherapy induced a blistering reaction followed by eruption of melanocytic nevi on the exposed skin surface of a child with transient neonatal porphyrinemia. New nevi are still developing 4 years after the triggering event. The role of phototoxicity-induced epidermal injury, that of porphyrins and the influence of neonatal blue-light therapy, in this unique phenomenon are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1111/pde.13569DOI Listing

Publication Analysis

Top Keywords

blistering reaction
8
melanocytic nevi
8
child transient
8
transient neonatal
8
neonatal porphyrinemia
8
neonatal blue-light
8
phototherapy-induced blistering
4
reaction eruptive
4
eruptive melanocytic
4
nevi child
4

Similar Publications

Background: Hailey-Hailey disease (HHD), a genetic blistering disease, is caused by a mutation in a calcium transporter protein in the Golgi apparatus encoded by the gene. Clinically, HHD is characterized by flaccid vesicles, blisters, erosions, fissures, and maceration mainly in intertriginous regions. Some patients remain refractory to conventional treatments.

View Article and Find Full Text PDF

Both the surgical non-cultured melanocyte-keratinocyte transplant procedure (MKTP) and intradermal injection of 5-Fluorouracil (5-FU) are effective in the treatment of vitiligo. Intrablisters injection of MKTP was done in one study with better results than MKTP application after ablative CO2 laser of the reciepient area. However, intrablister injection of 5-FU was not done before.

View Article and Find Full Text PDF

Fixed drug eruption (FDE) is a type of drug-induced skin inflammation characterized by the recurrence of lesions in the same region following repeated exposure to the causative drug. FDE typically presents as localized spots or plaques without systemic symptoms; however, it can manifest in other forms, such as blisters and papules. In FDE, effector memory CD8-positive T cells that remain dormant in the basal layer after a previous inflammation are reactivated upon re-exposure to the causative drug, leading to the development of erythema at the same sites.

View Article and Find Full Text PDF

Hospital Dermatology: Review of Research in 2023-2024.

Cutis

November 2024

Dr. Wei is from the Department of Dermatology, University of Washington, Seattle. Dr. Micheletti is from the Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Inpatient consultative dermatologists play a critical role in the care of hospitalized patients with skin disease. Our review of the 2023-2024 dermatology literature identified several areas of active investigation relevant to inpatient dermatology. In this article, we highlight advances in the understanding of severe cutaneous adverse drug reactions, diagnosis and prevention of skin and soft tissue infections, and management of autoimmune blistering diseases (AIBDs).

View Article and Find Full Text PDF

In this paper, we investigated the efficient metal-free phosphorus-nitrogen (PN) catalyst and used the PN catalyst to degrade waste PU with two-component binary mixed alcohols as the alcohol solvent. We examined the effects of reaction temperature, time, and other factors on the hydroxyl value and viscosity of the degradation products; focused on the changing rules of the hydroxyl value, viscosity, and molecular weight of polyols recovered from degradation products with different dosages of the metal-free PN catalyst; and determined the optimal experimental conditions of reaction temperature 180 °C, reaction time 3 h, and PN dosage 0.08%.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!